Success Metrics

Clinical Success Rate
91.5%

Based on 515 completed trials

Completion Rate
91%(515/563)
Active Trials
55(8%)
Results Posted
31%(160 trials)
Terminated
48(7%)

Phase Distribution

Ph phase_3
55
8%
Ph phase_2
53
7%
Ph phase_4
153
21%
Ph phase_1
336
46%
Ph early_phase_1
11
2%
Ph not_applicable
108
15%

Phase Distribution

347

Early Stage

53

Mid Stage

208

Late Stage

Phase Distribution716 total trials
Early Phase 1First-in-human
11(1.5%)
Phase 1Safety & dosage
336(46.9%)
Phase 2Efficacy & side effects
53(7.4%)
Phase 3Large-scale testing
55(7.7%)
Phase 4Post-market surveillance
153(21.4%)
N/ANon-phased studies
108(15.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.9%

515 of 586 finished

Non-Completion Rate

12.1%

71 ended early

Currently Active

55

trials recruiting

Total Trials

731

all time

Status Distribution
Active(72)
Completed(515)
Terminated(71)
Other(73)

Detailed Status

Completed515
unknown72
Terminated48
Recruiting39
Withdrawn23
Active, not recruiting16

Development Timeline

Analytics

Development Status

Total Trials
731
Active
55
Success Rate
91.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 111 (1.5%)
Phase 1336 (46.9%)
Phase 253 (7.4%)
Phase 355 (7.7%)
Phase 4153 (21.4%)
N/A108 (15.1%)

Trials by Status

withdrawn233%
enrolling_by_invitation20%
unknown7210%
recruiting395%
terminated487%
suspended10%
active_not_recruiting162%
not_yet_recruiting152%
completed51570%

Recent Activity

Clinical Trials (731)

Showing 20 of 731 trialsScroll for more
NCT07227454Phase 3

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Recruiting
NCT05355701Phase 1

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Recruiting
NCT06417125Phase 4

Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children

Completed
NCT06717269Phase 1

A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

Completed
NCT07656792Phase 1

A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood

Recruiting
NCT07665723Phase 1

An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

Recruiting
NCT07118215Phase 1

A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

Completed
NCT06916702Phase 1

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women

Recruiting
NCT06963112Phase 1

Intraoperative Midazolam on Delirium Outcome of Elderly Patients

Completed
NCT07426757Phase 1

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Recruiting
NCT07567781Phase 1

A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

Active Not Recruiting
NCT05681572Phase 3

Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia

Recruiting
NCT04560660Phase 2

Ketamine-enhanced Prolonged Exposure Therapy in PTSD

Completed
NCT07525544Phase 1

A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

Recruiting
NCT07699523Not Applicable

The Effects of Midazolam, Dexmedetomidine, and Esketamine on Bispectral Index and Raw Electroencephalogram in Patients Under Propofol-Remifentanil Baseline Anesthesia

Not Yet Recruiting
NCT03929744Phase 1

A Study of LY3502970 in Healthy Participants

Completed
NCT07340190Phase 1

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Recruiting
NCT07226635Phase 1

Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone

Completed
NCT02365597Phase 2

An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

Active Not Recruiting
NCT07570082Phase 1

Drug-Drug Interaction Study of Atumelnant in Healthy Participants

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
731